Indraprastha Apollo Hospitals has launched the Varian Edge® Radiosurgery System with Hyperarc Technology. The new system strengthens the hospital’s cancer care facilities. It also expands treatment options for complex and hard-to-reach tumours.
![]() |
Indraprastha Apollo Hospitals launches Varian Edge radiosurgery system
The technology combines precise radiation delivery with advanced motion management. As a result, doctors can target tumours while limiting radiation exposure to nearby healthy tissue.
Advanced Technology Tracks Tumour Movement
The Varian Edge® system tracks tumour movement during treatment. This feature helps doctors maintain accuracy when tumours shift due to breathing.
The platform also supports Deep Inspiration Breath Hold (DIBH). This technique can benefit patients with left-sided breast cancer. It helps reduce radiation exposure to the heart.
In addition, enhanced imaging improves treatment precision in several areas. These include the abdomen, liver, lungs, gastrointestinal tract and genitourinary system. These areas can present challenges because internal organs move during treatment.
Shorter Treatment Time for Multiple Tumours
Another key feature is the system’s ability to treat multiple metastases in a single session. This can reduce treatment time to less than one-third of conventional LINAC or SRS treatments.
The system synchronises the movement of the radiation beam and treatment couch. This allows continuous and precise radiation delivery. It can also reduce the number of radiation exposures, known as “hits”, and improve patient comfort.
Apollo Specialists Highlight Clinical Benefits
Dr G.K. Jadhav, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals, said:
“The Varian Edge platform gives us a sharper and more versatile tool to manage a wide spectrum of tumours from tiny lesions to large, complex cases, even in challenging locations. It meaningfully expands our treatment options and enhances clinical outcomes.”
Dr Sapna Manocha Verma, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals, added:
“What sets apart this technology is the radiation beam continuously tracks and adjusts to the tumour’s position, even as it shifts during breathing, while surrounding healthy tissue is carefully protected. The platform also supports advanced motion-management techniques such as Deep Inspiration Breath Hold (DIBH), which is particularly beneficial in left-sided breast tumours and in select liver and lung tumours. For patients, this translates into shorter treatment times, fewer side effects, and faster recovery.”
Dr Robin Khosa, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals, said:
“The Varian Edge® Radiosurgery System with Hyperarc Technology represents a major advancement in precision radiation therapy. Its ability to track tumours in real time and deliver radiation with submillimetre accuracy allows us to treat complex cases including multiple brain metastases and tumours previously considered difficult or untreatable with greater safety and confidence.”
The launch event also saw the presence of other radiation oncology specialists. They included Dr Mano Bhadauria and Dr Aditi Agarwal, Senior Consultants in Radiation Oncology at Indraprastha Apollo Hospitals. Dr Devashish Tripathi, Senior Consultant in Radiation Oncology at Apollo Hospitals, New Delhi, also attended.
Focus on Complex and Hard-to-Reach Tumours
The Varian Edge® system can support treatment for tumours in delicate or difficult-to-reach areas. In these cases, accurate targeting and motion management play an important role.
Its imaging quality and resolution help clinicians define treatment areas more precisely. This may allow doctors to reduce treatment margins and deliver higher radiation doses when clinically appropriate.
The approach also aims to limit damage to surrounding healthy tissue. However, treatment outcomes depend on each patient’s condition and clinical assessment.
Apollo Hospitals Expands Advanced Cancer Care
With this launch, Indraprastha Apollo Hospitals continues to expand its radiation oncology capabilities. The hospital combines advanced technology with a multidisciplinary team of oncologists, neurosurgeons, medical physicists and radiation specialists.
The hospital also offers other advanced treatment platforms. These include the ZAP-X Gyroscopic Radiosurgery Platform for non-invasive brain tumour treatment and the RADIXACT-X9 system for image-guided radiation therapy.
About Indraprastha Apollo Hospitals
Indraprastha Apollo Hospitals is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. The hospital began operations in July 1996 and is the third super-specialty tertiary care hospital established by the Apollo Hospitals Group.
Spread across 15 acres, the hospital offers 57 specialties and has more than 300 specialists. Its facilities include over 700 operational beds, 19 operation theatres and 138 ICU beds.
The hospital also provides 24-hour emergency services, pharmacy services, NABL-accredited laboratories and air ambulance services. It has a major kidney and liver transplant programme. The hospital also performed India’s first successful paediatric and adult liver transplants.
Indraprastha Apollo Hospitals offers advanced diagnostic, medical and surgical facilities. Its technology includes 64-slice CT, 3 Tesla MRI, Novalis Tx and an integrated PET Suite.
The hospital has also developed preventive health check-up programmes. It has consistently featured among India’s top 10 hospitals in The Week surveys in recent years.
For more information, visit Apollo Hospitals Delhi.


